Pamidronate Disodium Injection, Solution
Product Images NDC 61703-326

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pamidronate Disodium (NDC 61703-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Pamidronate 01)

FDA Label Image

Structural Formula Pamidronate Disodium (Pamidronate 01a)

FDA Label Image

Figure 1: Pamidronate Renal Clearance As A Function Of Creatinine Clearance In Patients With Normal And Impaired Renal Function. (Pamidronate 02)

FDA Label Image

Logo (Pamidronate 03)

FDA Label Image

Principal Display Panel (60 mg/10 mL Vial Label)

FDA Label Image

Principal Display Panel (60 mg/10 mL Vial Carton)

This text is a description of a medication called Pamidronate Disodium. Each vial of this medication contains 60 mg, for injection, which is adjusted to a pH range of 6.0 to 7.0 with phosphoric acid and/or sodium hydroxide. The medication must be stored at a controlled room temperature of 20-25°C and cannot be mixed with calcium-containing infusion solutions. The usual dosage instructions are provided in the package insert, and complete prescribing and product information should be read before administering. This medication is distributed by Hospira, Inc. in Lake Forest, IL, USA and is manufactured in Argentina.*

FDA Label Image

Principal Display Panel (90 mg/10 mL Vial Label)

FDA Label Image

Principal Display Panel (90 mg/10 mL Vial Carton)

Pamidronate Disodium is an injection solution that comes in a vial containing 90 mg of Pamidronate Disodium, mannitol, USP 375 mg, and water. The pH of the solution is adjusted between 6.0 - 7.0 with phosphoric acid and/or sodium hydroxide. The vial is to be stored at a temperature range of 20 to 25°C (68 to 77°F). The solution is for Intravenous Infusion only and should not be mixed with calcium-containing infusion solutions. The usual dosage is to be determined after reading the package insert with complete prescribing and product information. The product is distributed by Hospira Inc. in Lake Forest, IL, USA.  Made in Argentina.*

FDA Label Image

Principal Display Panel (30 mg/10 mL Vial Label)

FDA Label Image

Principal Display Panel (30 mg/10 mL Vial Carton)

This is a description of a medication called Pamidronate Disodium contained in vials of 30mg per 10mL. The medication is mixed with mannitol and water for injection. It can be adjusted in the range of 0-7.0 with phosphoric acid or sodium hydroxide as necessary, and should only be administered through IV infusion. The medication should not be mixed with calcium-containing infusion solutions. More information and instructions for use can be found in the package insert. The medication is distributed by Hospira, Inc. and is made in Argentina.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.